Skip to main content
Top
Published in: HAND 3/2011

01-09-2011 | Surgery Articles

A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren’s contracture

Authors: Neal C. Chen, Ramesh C. Srinivasan, Melissa J. Shauver, Kevin C. Chung

Published in: HAND | Issue 3/2011

Login to get access

Abstract

Background

Needle aponeurotomy and collagenase injection are alternative treatments of Dupuytren’s contracture to open partial fasciectomy; however, reported data are difficult to interpret without a formal systematic review.

Methods

A Medline, EMBASE, and Cochrane database search was performed, and 277 articles were identified. Articles were stratified by level of evidence, and those of the highest level for each technique were included. Evidence available for needle aponeurotomy was of low quality so only cohorts larger than 100 patients were included.

Results

The sample size of patients for open partial fasciectomy ranged from 37–261. The recurrence rate ranged from 12–39%, with mean follow-up time of 1.5–7.3 years. The complication rate ranged from 14–67%. Complications included nerve division (2–5%), infection (4–12%), neurapraxia (0.4–52%), and regional pain syndrome (2–13%). For needle aponeurotomy the sample size ranged from 117–211. The recurrence rate ranged from 50–58%, with mean follow-up time of 3–5 years. With regard to collagenase injection, the sample size ranged from 13–204. The recurrence rate ranged from 10–31%, with mean follow-up time of 120 days to 4 years. For the two latter procedures, adverse effects consisted primarily of skin tears (9–25%). Kruskal–Wallis testing demonstrated that the recurrence rate was significantly higher for needle aponeurotomy than for open partial fasciectomy (p = 0.001), and the recurrence rate was significantly higher for open partial fasciectomy than for collagenase injection (p = 0.001).

Conclusions

The recurrence rates and types of complications differ between open partial fasciectomy and needle aponeurotomy or collagenase injection. Long-term outcomes have not been well reported.
Literature
1.
go back to reference Badalamente MA, Hurst LC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg Am. 2000;25:629–36.PubMedCrossRef Badalamente MA, Hurst LC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg Am. 2000;25:629–36.PubMedCrossRef
2.
go back to reference Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am. 2007;32:767–74.PubMedCrossRef Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am. 2007;32:767–74.PubMedCrossRef
3.
go back to reference Badalamente MA, Hurst LC, Hentz VR. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg Am. 2002;27:788–98.PubMedCrossRef Badalamente MA, Hurst LC, Hentz VR. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg Am. 2002;27:788–98.PubMedCrossRef
4.
go back to reference Badois FJ, Lermusiaux JL, Masse C, Kuntz D. Non-surgical treatment of Dupuytren disease using needle fasciotomy. Rev Rhum Ed Fr. 1993;60:808–13.PubMed Badois FJ, Lermusiaux JL, Masse C, Kuntz D. Non-surgical treatment of Dupuytren disease using needle fasciotomy. Rev Rhum Ed Fr. 1993;60:808–13.PubMed
5.
go back to reference Balaguer T, David S, Ihrai T, Cardot N, Daideri G, Lebreton E. Histological staging and Dupuytren's disease recurrence or extension after surgical treatment: a retrospective study of 124 patients. J Hand Surg Eur. 2009;34:493–6. Balaguer T, David S, Ihrai T, Cardot N, Daideri G, Lebreton E. Histological staging and Dupuytren's disease recurrence or extension after surgical treatment: a retrospective study of 124 patients. J Hand Surg Eur. 2009;34:493–6.
6.
go back to reference Becker GW, Davis TR. The outcome of surgical treatments for primary Dupuytren's disease—a systematic review. J Hand Surg Eur. 2010;35:623–6. Becker GW, Davis TR. The outcome of surgical treatments for primary Dupuytren's disease—a systematic review. J Hand Surg Eur. 2010;35:623–6.
7.
go back to reference Bulstrode NW, Jemec B, Smith PJ. The complications of Dupuytren's contracture surgery. J Hand Surg Am. 2005;30:1021–5.PubMedCrossRef Bulstrode NW, Jemec B, Smith PJ. The complications of Dupuytren's contracture surgery. J Hand Surg Am. 2005;30:1021–5.PubMedCrossRef
8.
go back to reference Citron ND, Nunez V. Recurrence after surgery for Dupuytren's disease: a randomized trial of two skin incisions. J Hand Surg Br. 2005;30:563–6.PubMedCrossRef Citron ND, Nunez V. Recurrence after surgery for Dupuytren's disease: a randomized trial of two skin incisions. J Hand Surg Br. 2005;30:563–6.PubMedCrossRef
9.
go back to reference Coert JH, Nerin JP, Meek MF. Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients. Ann Plast Surg. 2006;57:13–7.PubMedCrossRef Coert JH, Nerin JP, Meek MF. Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients. Ann Plast Surg. 2006;57:13–7.PubMedCrossRef
10.
go back to reference Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg Br. 2003;28:427–31.PubMed Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg Br. 2003;28:427–31.PubMed
11.
go back to reference Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase Clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009;361:968–79.PubMedCrossRef Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase Clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009;361:968–79.PubMedCrossRef
12.
go back to reference Misra A, Jain A, Ghazanfar R, Johnston T, Nanchahal J. Predicting the outcome of surgery for the proximal interphalangeal joint in Dupuytren's disease. J Hand Surg Am. 2007;32:240–5.PubMedCrossRef Misra A, Jain A, Ghazanfar R, Johnston T, Nanchahal J. Predicting the outcome of surgery for the proximal interphalangeal joint in Dupuytren's disease. J Hand Surg Am. 2007;32:240–5.PubMedCrossRef
13.
go back to reference Mushlin AI, Ghomrawi H. Health care reform and the need for comparative-effectiveness research. N Engl J Med. 2010;362:e6.PubMedCrossRef Mushlin AI, Ghomrawi H. Health care reform and the need for comparative-effectiveness research. N Engl J Med. 2010;362:e6.PubMedCrossRef
14.
go back to reference Rombouts JJ, Noel H, Legrain Y, Munting E. Prediction of recurrence in the treatment of Dupuytren's disease: evaluation of a histologic classification. J Hand Surg Am. 1989;14:644–52.PubMedCrossRef Rombouts JJ, Noel H, Legrain Y, Munting E. Prediction of recurrence in the treatment of Dupuytren's disease: evaluation of a histologic classification. J Hand Surg Am. 1989;14:644–52.PubMedCrossRef
15.
go back to reference Roush TF, Stern PJ. Results following surgery for recurrent Dupuytren's disease. J Hand Surg Am. 2000;25:291–6.PubMedCrossRef Roush TF, Stern PJ. Results following surgery for recurrent Dupuytren's disease. J Hand Surg Am. 2000;25:291–6.PubMedCrossRef
16.
go back to reference Ullah AS, Dias JJ, Bhowal B. Does a 'firebreak' full-thickness skin graft prevent recurrence after surgery for Dupuytren's contracture?: a prospective, randomised trial. J Bone Joint Surg Br. 2009;91:374–8.PubMedCrossRef Ullah AS, Dias JJ, Bhowal B. Does a 'firebreak' full-thickness skin graft prevent recurrence after surgery for Dupuytren's contracture?: a prospective, randomised trial. J Bone Joint Surg Br. 2009;91:374–8.PubMedCrossRef
17.
go back to reference van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am. 2006;31:717–25.PubMedCrossRef van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am. 2006;31:717–25.PubMedCrossRef
18.
go back to reference Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up. J Hand Surg Am. 2010;35:534–9. 9.e1.PubMedCrossRef Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up. J Hand Surg Am. 2010;35:534–9. 9.e1.PubMedCrossRef
Metadata
Title
A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren’s contracture
Authors
Neal C. Chen
Ramesh C. Srinivasan
Melissa J. Shauver
Kevin C. Chung
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
HAND / Issue 3/2011
Print ISSN: 1558-9447
Electronic ISSN: 1558-9455
DOI
https://doi.org/10.1007/s11552-011-9326-8

Other articles of this Issue 3/2011

HAND 3/2011 Go to the issue